These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 21823650

  • 1. Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.
    Ramanathan S, Mazzalupo S, Boitano S, Montfort WR.
    Biochemistry; 2011 Sep 13; 50(36):7787-99. PubMed ID: 21823650
    [Abstract] [Full Text] [Related]

  • 2. Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.
    Miller TW, Isenberg JS, Roberts DD.
    Br J Pharmacol; 2010 Apr 13; 159(7):1542-7. PubMed ID: 20233213
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase.
    Murthy KS.
    J Pharmacol Exp Ther; 2008 Apr 13; 325(1):183-9. PubMed ID: 18180373
    [Abstract] [Full Text] [Related]

  • 4. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
    Morbidelli L, Pyriochou A, Filippi S, Vasileiadis I, Roussos C, Zhou Z, Loutrari H, Waltenberger J, Stössel A, Giannis A, Ziche M, Papapetropoulos A.
    Am J Physiol Regul Integr Comp Physiol; 2010 Mar 13; 298(3):R824-32. PubMed ID: 20032260
    [Abstract] [Full Text] [Related]

  • 5. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
    El-Sehemy A, Chang AC, Azad AK, Gupta N, Xu Z, Steed H, Karsan A, Fu Y.
    Cell Signal; 2013 Dec 13; 25(12):2780-7. PubMed ID: 24041655
    [Abstract] [Full Text] [Related]

  • 6. Soluble guanylate cyclase modulators blunt hyperoxia effects on calcium responses of developing human airway smooth muscle.
    Britt RD, Thompson MA, Kuipers I, Stewart A, Vogel ER, Thu J, Martin RJ, Pabelick CM, Prakash YS.
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep 15; 309(6):L537-42. PubMed ID: 26254425
    [Abstract] [Full Text] [Related]

  • 7. Nucleotide regulation of soluble guanylate cyclase substrate specificity.
    Derbyshire ER, Fernhoff NB, Deng S, Marletta MA.
    Biochemistry; 2009 Aug 11; 48(31):7519-24. PubMed ID: 19527054
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
    Bellamy TC, Garthwaite J.
    Br J Pharmacol; 2002 May 11; 136(1):95-103. PubMed ID: 11976273
    [Abstract] [Full Text] [Related]

  • 9. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
    Crassous PA, Couloubaly S, Huang C, Zhou Z, Baskaran P, Kim DD, Papapetropoulos A, Fioramonti X, Durán WN, Beuve A.
    Am J Physiol Heart Circ Physiol; 2012 Sep 01; 303(5):H597-604. PubMed ID: 22730391
    [Abstract] [Full Text] [Related]

  • 10. cIMP synthesized by sGC as a mediator of hypoxic contraction of coronary arteries.
    Chen Z, Zhang X, Ying L, Dou D, Li Y, Bai Y, Liu J, Liu L, Feng H, Yu X, Leung SW, Vanhoutte PM, Gao Y.
    Am J Physiol Heart Circ Physiol; 2014 Aug 01; 307(3):H328-36. PubMed ID: 24906916
    [Abstract] [Full Text] [Related]

  • 11. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
    Mendes-Silverio CB, Leiria LO, Morganti RP, Anhê GF, Marcondes S, Mónica FZ, De Nucci G, Antunes E.
    PLoS One; 2012 Aug 01; 7(11):e47223. PubMed ID: 23144808
    [Abstract] [Full Text] [Related]

  • 12. Salvianolic acid B possesses vasodilation potential through NO and its related signals in rabbit thoracic aortic rings.
    Shou Q, Pan Y, Xu X, Xu J, Wang D, Ling Y, Chen M.
    Eur J Pharmacol; 2012 Dec 15; 697(1-3):81-7. PubMed ID: 23051676
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity.
    Zhou Z, Sayed N, Pyriochou A, Roussos C, Fulton D, Beuve A, Papapetropoulos A.
    Arterioscler Thromb Vasc Biol; 2008 Oct 15; 28(10):1803-10. PubMed ID: 18635821
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calcium.
    Kazerounian S, Pitari GM, Ruiz-Stewart I, Schulz S, Waldman SA.
    Biochemistry; 2002 Mar 12; 41(10):3396-404. PubMed ID: 11876648
    [Abstract] [Full Text] [Related]

  • 15. YC-1 binding to the β subunit of soluble guanylyl cyclase overcomes allosteric inhibition by the α subunit.
    Purohit R, Fritz BG, The J, Issaian A, Weichsel A, David CL, Campbell E, Hausrath AC, Rassouli-Taylor L, Garcin ED, Gage MJ, Montfort WR.
    Biochemistry; 2014 Jan 14; 53(1):101-14. PubMed ID: 24328155
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S, Sips P, Buys E, Brouckaert P, Van de Voorde J.
    Cardiovasc Res; 2007 Oct 01; 76(1):149-59. PubMed ID: 17610859
    [Abstract] [Full Text] [Related]

  • 18. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C, Kern J, Heitz M, Plas E, Zwerschke W, Mattesich M, Sandner P, Berger P.
    Exp Cell Res; 2015 Nov 01; 338(2):162-9. PubMed ID: 26410556
    [Abstract] [Full Text] [Related]

  • 19. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.
    Priviero FB, Zemse SM, Teixeira CE, Webb RC.
    Am J Hypertens; 2009 May 01; 22(5):493-9. PubMed ID: 19247264
    [Abstract] [Full Text] [Related]

  • 20. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2004 Feb 01; 18(2):458-70. PubMed ID: 14630997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.